New Insight: Phase 2 BEHOLD Study and UBX1325 for DME, Live at AAO 2023

from HCPLive Podcasts · host HCPLive.com

On the floor at AAO 2023, host Veeral Sheth, MD, and producer Connor Iapoce discuss UBX1325 for patients with diabetic macular edema, based on the 48-week results from the phase 2 BEHOLD study. Episode Highlights:0:30 Introduction0:48 Background into UBX1325 and BEHOLD2:49 BEHOLD 48-week results6:05 Next steps6:56 ConclusionPlease direct any podcast-related inquiries to [email protected].

Episode metadata supplied by the publisher feed · Published Nov 5, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

New Insight: Phase 2 BEHOLD Study and UBX1325 for DME, Live at AAO 2023

0:00 7:24

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of HCPLive Podcasts?

This episode is 7 minutes long.

When was this HCPLive Podcasts episode published?

This episode was published on November 5, 2023.

Can I download this HCPLive Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!